Smith+Nephew is a medical technology company specializing in orthopedics, sports medicine, and advanced wound management. Its products include joint reconstruction implants, arthroscopy and trauma devices, and wound-care systems used by hospitals and surgeons. The business serves healthcare providers worldwide with surgical and treatment technologies rather than pharmaceuticals.
| Year | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| 2022 | 5,215 | — | 223 | — |
| 2023 | 5,549 | 6.4% | 263 | 17.9% |
| 2024 | 5,810 | 4.7% | 412 | 56.6% |
| 2025 | 6,164 | 6.1% | 625 | 51.7% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Applied Industrial Technologies, Inc. (AIT), Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (PAC), DaVita Inc. (DVA), Watts Water Technologies, Inc. (WTS), Crane Company (CR), Antero Resources Corporation (AR)